標(biāo)準(zhǔn)解讀
《GB/T 18646-2025 動(dòng)物布魯氏菌病診斷技術(shù)》相較于《GB/T 18646-2018 動(dòng)物布魯氏菌病診斷技術(shù)》,在多個(gè)方面進(jìn)行了更新和改進(jìn)。首先,在術(shù)語(yǔ)定義部分,新版標(biāo)準(zhǔn)對(duì)某些專業(yè)術(shù)語(yǔ)進(jìn)行了更準(zhǔn)確的界定,并新增了一些與最新研究進(jìn)展相關(guān)的術(shù)語(yǔ),以確保所有使用者能夠基于同一理解基礎(chǔ)進(jìn)行交流。
其次,關(guān)于檢測(cè)方法,新版本增加了幾種最新的分子生物學(xué)檢測(cè)手段,如數(shù)字PCR等,這些技術(shù)的應(yīng)用提高了布魯氏菌病診斷的靈敏度與特異性。同時(shí),對(duì)于傳統(tǒng)血清學(xué)試驗(yàn)(例如玫瑰花環(huán)試驗(yàn)、試管凝集試驗(yàn))的具體操作步驟也做了細(xì)化說明,增強(qiáng)了實(shí)驗(yàn)結(jié)果的一致性和可靠性。
此外,《GB/T 18646-2025》還特別強(qiáng)調(diào)了實(shí)驗(yàn)室生物安全要求,針對(duì)不同級(jí)別的生物安全實(shí)驗(yàn)室提出了具體的操作指南及防護(hù)措施建議,旨在保障實(shí)驗(yàn)人員健康的同時(shí)提高檢測(cè)準(zhǔn)確性。
最后,在質(zhì)量控制方面,新版標(biāo)準(zhǔn)增加了更多關(guān)于內(nèi)部質(zhì)控品的選擇與使用指導(dǎo),以及外部質(zhì)量評(píng)估程序的相關(guān)內(nèi)容,通過加強(qiáng)質(zhì)量管理體系來進(jìn)一步提升整個(gè)診斷流程的專業(yè)水平。
如需獲取更多詳盡信息,請(qǐng)直接參考下方經(jīng)官方授權(quán)發(fā)布的權(quán)威標(biāo)準(zhǔn)文檔。
....
查看全部
- 現(xiàn)行
- 正在執(zhí)行有效
- 2025-05-30 頒布
- 2025-12-01 實(shí)施
文檔簡(jiǎn)介
ICS11.220
CCSB41
中華人民共和國(guó)國(guó)家標(biāo)準(zhǔn)
GB/T18646—2025
代替GB/T18646—2018
動(dòng)物布魯氏菌病診斷技術(shù)
Diagnostictechniquesforanimalbrucellosis
2025?05?30發(fā)布2025?12?01實(shí)施
國(guó)家市場(chǎng)監(jiān)督管理總局
國(guó)家標(biāo)準(zhǔn)化管理委員會(huì)發(fā)布
GB/T18646—2025
目次
前言··························································································································Ⅴ
引言··························································································································Ⅵ
1范圍·······················································································································1
2規(guī)范性引用文件········································································································1
3術(shù)語(yǔ)和定義··············································································································1
4縮略語(yǔ)····················································································································1
5臨床診斷·················································································································2
5.1流行特點(diǎn)···········································································································2
5.2臨床癥狀···········································································································2
5.3病理變化···········································································································3
5.4結(jié)果判定···········································································································3
6樣品采集、保存、運(yùn)輸及處理·························································································3
6.1儀器設(shè)備···········································································································3
6.2試劑材料···········································································································3
6.3樣品采集···········································································································3
6.4樣品運(yùn)輸和保存··································································································4
6.5樣品處理···········································································································4
7病原學(xué)診斷方法········································································································5
7.1改良萋?尼氏(Ziehl?Neelsen)抗酸染色·······································································5
7.2布魯氏菌分離與鑒定····························································································6
7.3實(shí)時(shí)熒光PCR方法······························································································7
7.4熒光RAA方法···································································································9
7.5多重PCR方法··································································································11
8免疫學(xué)診斷方法······································································································12
8.1標(biāo)準(zhǔn)血清··········································································································12
8.2虎紅平板凝集試驗(yàn)(RBT)····················································································13
8.3試管凝集試驗(yàn)(SAT)··························································································14
8.4補(bǔ)體結(jié)合試驗(yàn)(CFT)···························································································17
8.5間接ELISA抗體檢測(cè)方法(iELISA)······································································22
8.6競(jìng)爭(zhēng)ELISA抗體檢測(cè)方法(cELISA)······································································24
8.7熒光偏振試驗(yàn)(FPA)···························································································26
8.8全乳環(huán)狀試驗(yàn)(MRT)(僅適用于牛)········································································29
8.9免疫層析法(ICA)······························································································30
Ⅰ
GB/T18646—2025
9綜合判定···············································································································30
9.1布魯氏菌疑似感染動(dòng)物判定···············································································30
9.2布魯氏菌感染動(dòng)物判定·····················································································31
附錄A(資料性)檢測(cè)方法的適用性················································································32
附錄B(規(guī)范性)布魯氏菌培養(yǎng)基的配制··········································································33
B.1基礎(chǔ)培養(yǎng)基······································································································33
B.2血清葡萄糖培養(yǎng)基·····························································································33
B.3選擇培養(yǎng)基······································································································33
附錄C(規(guī)范性)生化反應(yīng)試劑的配制·············································································34
C.1結(jié)晶紫儲(chǔ)備液和工作液配制·················································································34
C.2氧化酶試驗(yàn)試劑配制··························································································34
C.3尿素酶活性試驗(yàn)培養(yǎng)基配方及制備········································································34
附錄D(規(guī)范性)布魯氏菌種和生物型的生化鑒定······························································35
附錄E(規(guī)范性)實(shí)時(shí)熒光PCR、RAA及多重PCR引物和探針序列·······································37
附錄F(規(guī)范性)多重PCR溶液配制及結(jié)果判定·······························································39
F.1TAE電泳緩沖液·······························································································39
F.21.5%瓊脂糖凝膠·······························································································39
F.3多重PCR判定標(biāo)準(zhǔn)····························································································39
附錄G(規(guī)范性)試管凝集試驗(yàn)(SAT)試劑的配制·····························································40
G.1含0.5%苯酚的生理鹽水·····················································································40
G.2含0.5%苯酚的10%氯化鈉溶液··········································································40
G.3參照比濁管的制備·····························································································40
附錄H(規(guī)范性)補(bǔ)體結(jié)合試驗(yàn)(CFT)試劑的配制及效價(jià)測(cè)定··············································41
H.1稀釋液配制······································································································41
H.2綿羊紅細(xì)胞懸液的配制(2.5%)·············································································41
H.3溶血素效價(jià)測(cè)定································································································41
H.4補(bǔ)體制備及效價(jià)測(cè)定··························································································44
H.5抗原效價(jià)的測(cè)定································································································49
H.6溶血標(biāo)準(zhǔn)比色管的制備及補(bǔ)體結(jié)合試驗(yàn)結(jié)果判定方法················································50
H.7待檢血清的稀釋和滅活·······················································································51
附錄I(規(guī)范性)酶聯(lián)免疫吸附試驗(yàn)(ELISA)試劑的制備······················································52
I.1包被抗原LPS提取·····························································································52
I.2包被液(0.05mol/L的pH9.6碳酸鹽緩沖液)····························································52
I.3封閉液(含2%BSA、0.05%吐溫?20的pH7.4PBS)···················································52
I.4樣品稀釋液(含1%BSA的pH7.4PBS)··································································52
I.5洗滌液(含0.05%吐溫?20的pH7.4PBS)································································52
Ⅱ
GB/T18646—2025
I.6顯色液·············································································································52
I.7終止液(2mol/L硫酸)·························································································53
附錄J(資料性)競(jìng)爭(zhēng)酶聯(lián)免疫吸附試驗(yàn)(cELISA)單克隆抗體的制備·····································54
附錄K(規(guī)范性)熒光偏振試驗(yàn)(FPA)抗原和稀釋液的制備··················································55
K.1標(biāo)記抗原的制備································································································55
K.2樣品稀釋液的配制·····························································································55
參考文獻(xiàn)····················································································································56
Ⅲ
GB/T18646—2025
前言
本文件按照GB/T1.1—2020《標(biāo)準(zhǔn)化工作導(dǎo)則第1部分:標(biāo)準(zhǔn)化文件的結(jié)構(gòu)和起草規(guī)則》的規(guī)
定起草。
本文件代替GB/T18646—2018《動(dòng)物布魯氏菌病診斷技術(shù)》,與GB/T18646—2018相比,除結(jié)構(gòu)
調(diào)整和編輯性改動(dòng)外,主要技術(shù)變化如下:
a)更改了“范圍”(見第1章,2018年版的第1章);
b)更改了“臨床診斷”,增加了流行病學(xué)、臨床癥狀和病理變化內(nèi)容(見第5章,2018年版的4.1、
4.2、4.3);
c)增加了“實(shí)時(shí)熒光PCR方法”“熒光RAA方法”(見7.3和7.4);
d)將“布魯氏菌Bruce?Ladder檢測(cè)方法”更改為“多重PCR方法”(見7.5,2018年版的4.13);
e)增加了免疫學(xué)診斷方法中RBT、SAT、CFT、iELISA、cELISA和FPA方法的標(biāo)準(zhǔn)化內(nèi)容(見
第8章);
f)更改了“虎紅平板凝集試驗(yàn)(RBT)”(見8.2,2018年版的4.4)、“間接ELISA抗體檢測(cè)方法
(iELISA)”(見8.5,2018年版的4.8)、“競(jìng)爭(zhēng)ELISA抗體檢測(cè)方法(cELISA)”(見8.6,2018
年版的4.9);
g)增加了“熒光偏振試驗(yàn)(FPA)”“免疫層析法(ICA)”(見8.7和8.9)。
本文件由中華人民共和國(guó)農(nóng)業(yè)農(nóng)村部提出。
本文件由全國(guó)動(dòng)物衛(wèi)生標(biāo)準(zhǔn)化技術(shù)委員會(huì)(SAC/TC181)歸口。
本文件起草單位:中國(guó)動(dòng)物衛(wèi)生與流行病學(xué)中心、中國(guó)獸醫(yī)藥品監(jiān)察所、中國(guó)動(dòng)物疫病預(yù)防控制中
心、中國(guó)農(nóng)業(yè)科學(xué)院哈爾濱獸醫(yī)研究所、中國(guó)疾病預(yù)防控制中心、新疆生產(chǎn)建設(shè)兵團(tuán)畜牧獸醫(yī)工作總
站、遼寧省動(dòng)物疫病預(yù)防控制中心、內(nèi)蒙古自治區(qū)動(dòng)物疫病預(yù)防控制中心、上海市動(dòng)物疫病預(yù)防控制中
心、河南省動(dòng)物疫病預(yù)防控制中心、重慶市動(dòng)物疫病預(yù)防控制中心、浙江省動(dòng)物疫病預(yù)防控制中心、
青島市動(dòng)物疫病預(yù)防控制中心。
本文件主要起草人:孫淑芳、李俊平、邵衛(wèi)星、孫明軍、姜海、南文龍、田莉莉、樊曉旭、焉鑫、孫雨、
胡森、李巖、朱良全、王建龍、閆若潛、張存瑞、李彥、顧貴波、趙洪進(jìn)、董春霞、趙靈燕、郭宇、孫翔翔、劉蒙達(dá)、
張皓博、孫世雄、李嘉琪。
本文件及其所代替文件的歷次版本發(fā)布情況為:
——2002年首次發(fā)布為GB/T18646—2002,2018年第一次修訂;
——本次為第二次修訂。
Ⅴ
GB/T18646—2025
引言
布魯氏菌?。˙rucellosis)是由布魯氏菌(Brucella)感染動(dòng)物和人而引起的一種人獸共患傳染病。
目前已報(bào)道的布魯氏菌屬成員包括6個(gè)經(jīng)典種、5個(gè)新鑒定種及部分未確定種型的非典型布魯氏菌。
經(jīng)典種包括羊種布魯氏菌(Brucellamelitensis)、牛種布魯氏菌(Brucellaabortus)、豬種布魯氏菌(Bru?
cellasuis)、綿羊附睪種布魯氏菌(Brucellaovis)、犬種布魯氏菌(Brucellacanis)和沙林鼠種布魯氏菌
(Brucellaneotomae);新鑒定種包括鯨種布魯氏菌(Brucellaceti)、鰭種布魯氏菌(Brucellapinnipedia?
lis)、田鼠種布魯氏菌(Brucellamicroti)、人源布魯氏菌(Brucellainopinata,暫未確定其他動(dòng)物宿主)和
狒狒種布魯氏菌(Brucellapapionis);未確定種型的包括分離自嚙齒類、狐類和蛙類的非典型布魯氏菌。
本文件主要規(guī)定了對(duì)畜牧業(yè)影響最大的羊種布魯氏菌、牛種布魯氏菌和豬種布魯氏菌三種光滑型布魯
氏菌引起的動(dòng)物布魯氏菌病相關(guān)診斷檢測(cè)技術(shù)內(nèi)容,僅在病原鑒定及PCR檢測(cè)方法中涉及了粗糙型
的綿羊附睪種和犬種布魯氏菌檢測(cè)。
布魯氏菌病在全世界范圍內(nèi)嚴(yán)重威脅動(dòng)物和人類健康。世界動(dòng)物衛(wèi)生組織(WorldOrganization
ofAnimalHealth,WOAH)將布魯氏菌病列入通報(bào)病種名錄,我國(guó)農(nóng)業(yè)農(nóng)村部發(fā)布的《一、二、三類動(dòng)物
疫病病種名錄》將布魯氏菌病列為二類動(dòng)物疫病,國(guó)家衛(wèi)生健康委員會(huì)將布魯氏菌病列為法定報(bào)告乙
類傳染病。從事布魯氏菌病診斷相關(guān)的樣品采集、包裝運(yùn)輸、檢測(cè)診斷等活動(dòng)的人員,經(jīng)過嚴(yán)格培訓(xùn),
在相應(yīng)級(jí)別的生物安全防護(hù)條件下進(jìn)行試驗(yàn)活動(dòng)。
本文件參考了WOAH《陸生動(dòng)物診斷試驗(yàn)與疫苗手冊(cè)》3.1.4章“布魯氏菌病(牛種、羊種和豬種布
魯氏菌感染)(2022版)”規(guī)定的診斷技術(shù)方法,包括臨床診斷、病原學(xué)診斷方法(涂片鏡檢、分離與鑒
定、實(shí)時(shí)熒光PCR方法)及免疫學(xué)診斷方法[虎紅平板凝集試驗(yàn)(RBT)、試管凝集試驗(yàn)(SAT)、補(bǔ)體結(jié)
合試驗(yàn)(CFT)、間接ELISA抗體檢測(cè)方法(iELISA)、競(jìng)爭(zhēng)ELISA抗體檢測(cè)方法(cELISA)、熒光偏振
試驗(yàn)(FPA)和全乳環(huán)狀試驗(yàn)(MRT)];并根據(jù)我國(guó)技術(shù)發(fā)展增加了技術(shù)成熟的熒光RAA方法和免疫
層析法(ICA)。
本文件的發(fā)布機(jī)構(gòu)提請(qǐng)注意,聲明相關(guān)產(chǎn)品符合本文件時(shí),可能涉及本文件7.3中引物和探針序
列與《一種區(qū)分布魯氏菌A19疫苗株與野毒株的分子標(biāo)記》(授權(quán)公告號(hào):CN113186312B)、《鑒別布魯
氏菌疫苗株S2和野毒株的SNP分子標(biāo)記及其應(yīng)用》(授權(quán)公告號(hào):CN111793704B)相關(guān)專利的使用。
本文件的發(fā)布機(jī)構(gòu)對(duì)于涉及專利的真實(shí)性、有效性和范圍無(wú)任何立場(chǎng)。
該專利持有人已向本文件的發(fā)布機(jī)構(gòu)承諾,同意在公平、合理、無(wú)歧視基礎(chǔ)上,免費(fèi)許可任何組織
或個(gè)人在實(shí)施該國(guó)家標(biāo)準(zhǔn)時(shí)實(shí)施專利。該專利持有人的聲明已在本文件的發(fā)布機(jī)構(gòu)備案。相關(guān)信息
可以通過以下聯(lián)系方式獲得:
專利(授權(quán)公告號(hào):CN113186312B)持有人姓名:中國(guó)動(dòng)物衛(wèi)生與流行病學(xué)中心。
地址:山東省青島市市北區(qū)南京路369號(hào)。
專利(授權(quán)公告號(hào):CN111793704B)持有
溫馨提示
- 1. 本站所提供的標(biāo)準(zhǔn)文本僅供個(gè)人學(xué)習(xí)、研究之用,未經(jīng)授權(quán),嚴(yán)禁復(fù)制、發(fā)行、匯編、翻譯或網(wǎng)絡(luò)傳播等,侵權(quán)必究。
- 2. 本站所提供的標(biāo)準(zhǔn)均為PDF格式電子版文本(可閱讀打?。?,因數(shù)字商品的特殊性,一經(jīng)售出,不提供退換貨服務(wù)。
- 3. 標(biāo)準(zhǔn)文檔要求電子版與印刷版保持一致,所以下載的文檔中可能包含空白頁(yè),非文檔質(zhì)量問題。
最新文檔
- 醫(yī)療器械使用及維護(hù)管理方案
- 軟件開發(fā)團(tuán)隊(duì)任務(wù)分配方案
- 市場(chǎng)調(diào)研數(shù)據(jù)分析與報(bào)告編制
- 起重設(shè)備維修、維保承包方案
- 某眼科醫(yī)院績(jī)效考核方案
- 標(biāo)準(zhǔn)個(gè)人簡(jiǎn)歷
- 1.5MW光伏發(fā)電項(xiàng)目成本預(yù)算全解析
- 幼兒科學(xué)探究活動(dòng)《橋梁》設(shè)計(jì)方案
- 語(yǔ)文教師教學(xué)論在線作業(yè)答題指南
- 小學(xué)作文篇開頭結(jié)尾萬(wàn)能模板集錦
- 2026年陜西西安市高三高考一模數(shù)學(xué)試卷試題(含答案詳解)
- 外事工作培訓(xùn)
- 鎮(zhèn)海區(qū)國(guó)資系統(tǒng)招聘筆試題庫(kù)2026
- 2025至2030中國(guó)高壓套管行業(yè)調(diào)研及市場(chǎng)前景預(yù)測(cè)評(píng)估報(bào)告
- 廣州市2026屆高一數(shù)學(xué)第一學(xué)期期末統(tǒng)考試題含解析
- AI在建筑中的應(yīng)用【演示文檔課件】
- 2026秋招:國(guó)家電投面試題及答案
- 2024至2030年中國(guó)紙類香袋數(shù)據(jù)監(jiān)測(cè)研究報(bào)告
- 面向工業(yè)智能化時(shí)代的新一代工業(yè)控制體系架構(gòu)白皮書
- 2024年四川省成都市青羊區(qū)中考數(shù)學(xué)二診試卷(含答案)
- 左心導(dǎo)管檢查及造影操作技術(shù)規(guī)范
評(píng)論
0/150
提交評(píng)論